Myocardial contrast echocardiography in acute myocardial infarction using aortic root injections of microbubbles in conjunction with harmonic imaging: potential application in the cardiac catheterization laboratory.

[1]  J. Y. Yang,et al.  Pharmacological stress thallium scintigraphy with 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470). A novel, short-acting adenosine A2A receptor agonist. , 1996, Circulation.

[2]  S. Kaul,et al.  Contractile Versus Microvascular Reserve for the Determination of the Extent of Myocardial Salvage After Reperfusion The Effect of Residual Coronary Stenosis , 1996 .

[3]  S. Kaul,et al.  Coronary reserve abnormalities in the infarcted myocardium. Assessment of myocardial viability immediately versus late after reflow by contrast echocardiography. , 1996, Circulation.

[4]  P. Burns.  Harmonic imaging with ultrasound contrast agents. , 1996, Clinical radiology.

[5]  T. Porter,et al.  Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles. Demonstration and potential mechanisms. , 1995, Circulation.

[6]  D. Bach,et al.  Intracoronary and aortic root myocardial contrast echocardiography: the effect of route, dose, and pharmacologic coronary vasodilation. , 1995, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[7]  M. Quiñones,et al.  Myocardial contrast echocardiography: relation of collateral perfusion to extent of injury and severity of contractile dysfunction in a canine model of coronary thrombosis and reperfusion. , 1995, Journal of the American College of Cardiology.

[8]  D. Bach,et al.  Regional heterogeneity on myocardial contrast echocardiography without severe obstructive coronary artery disease. , 1995, The American journal of cardiology.

[9]  S. Kaul,et al.  Identification of viable myocardium with contrast echocardiography in patients with poor left ventricular systolic function caused by recent or remote myocardial infarction. , 1995, The American journal of cardiology.

[10]  S. Kaul,et al.  Quantification of Images Obtained During Myocardial Contrast Echocardiography , 1994, Echocardiography.

[11]  S. Kaul,et al.  Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography. , 1994, Circulation.

[12]  M. Cerqueira,et al.  Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. , 1994, Journal of the American College of Cardiology.

[13]  S. Kaul,et al.  Characterization of Spatial Patterns of Flow Within the Reperfused Myocardium by Myocardial Contrast Echocardiography Implications in Determining Extent of Myocardial Salvage , 1993, Circulation.

[14]  P. Serruys,et al.  Intracoronary albunex. Its effects on left ventricular hemodynamics, function, and coronary sinus flow in humans. , 1993, Circulation.

[15]  J O'Keefe,et al.  A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .

[16]  S. Kaul,et al.  An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. , 1992, The New England journal of medicine.

[17]  S. Kaul,et al.  Functional Significance of Collateral Blood Flow in Patients With Recent Acute Myocardial Infarction: A Study Using Myocardial Contrast Echocardiography , 1992, Circulation.

[18]  A. Kitabatake,et al.  Lack of Myocardial Perfusion Immediately After Successful Thrombolysis: A Predictor of Poor Recovery of Left Ventricular Function in Anterior Myocardial Infarction , 1992, Circulation.

[19]  V. Newhouse,et al.  Simulated Capillary Blood Flow Measurement Using a Nonlinear Ultrasonic Contrast Agent1 , 1992 .

[20]  S. Kaul,et al.  Relation between anterograde blood flow through a coronary artery and the size of the perfusion bed it supplies: experimental and clinical implications. , 1991, Journal of the American College of Cardiology.

[21]  F. Van de Werf,et al.  Evidence for decreased coronary flow reserve in viable postischemic myocardium. , 1990, Circulation research.

[22]  A Ranhosky,et al.  The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group. , 1990, Circulation.

[23]  A R Jayaweera,et al.  Method for the quantitation of myocardial perfusion during myocardial contrast two-dimensional echocardiography. , 1990, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[24]  J. O’Meara,et al.  Ability of dipyridamole-thallium-201 imaging one to four days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events. , 1990, The American journal of cardiology.

[25]  S. Kaul,et al.  Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[26]  D D Watson,et al.  Myocardial contrast echocardiography in humans. II. Assessment of coronary blood flow reserve. , 1988, Journal of the American College of Cardiology.

[27]  J. Bristow,et al.  No reflow and extent of infarction during maximal vasodilation in the porcine heart. , 1988, Circulation.

[28]  M. S. Klein,et al.  Assessment of myocardial perfusion in humans by contrast echocardiography. I. Evaluation of regional coronary reserve by peak contrast intensity. , 1988, Journal of the American College of Cardiology.

[29]  A. Weyman,et al.  Effects of selectively altering collateral driving pressure on regional perfusion and function in occluded coronary bed in the dog. , 1987, Circulation research.

[30]  A. Weyman,et al.  The importance of defining left ventricular area at risk in vivo during acute myocardial infarction: an experimental evaluation with myocardial contrast two-dimensional echocardiography. , 1987, Circulation.

[31]  T. Force,et al.  In vivo prediction of the transmural extent of experimental acute myocardial infarction using contrast echocardiography. , 1986, Journal of the American College of Cardiology.

[32]  W. Ganz,et al.  The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.

[33]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.

[34]  G M Pohost,et al.  Contrast echocardiography in acute myocardial ischemia: I. In vivo determination of total left ventricular "area at risk". , 1984, Journal of the American College of Cardiology.

[35]  M. Fishbein,et al.  Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. , 1981, American heart journal.

[36]  E. Braunwald,et al.  Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size aftr experimental coronary artery occlusion. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[37]  C. Bloor,et al.  Regional redistribution of myocardial blood flow after coronary occlusion and reperfusion in the conscious dog. , 1978, The American journal of cardiology.

[38]  J. Greenfield,et al.  Local effects of acute cellular injury on regional myocardial blood flow. , 1976, The Journal of clinical investigation.

[39]  R. Kloner,et al.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog. , 1974, The Journal of clinical investigation.